Recruiting studies: Retinitis Pigmentosa 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

InsightRP2 Registry
Phase N/A · 1 location(s) · University of Göttingen · NCT06982417 Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06623110 Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation
Phase 1/Phase 2 · 1 location(s) · Chigenovo Co., Ltd · NCT06952842 Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Phase 2 · 14 location(s) · jCyte, Inc · NCT06912633 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168 Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
Phase 1/Phase 2 · 3 location(s) · AAVantgarde Bio Srl · NCT06591793 BS01 in Patients With Retinitis Pigmentosa
Phase 1/Phase 2 · 1 location(s) · Bionic Sight LLC · NCT04278131 Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Phase 2 · 12 location(s) · Replimune, Inc. · NCT05733598 A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Phase N/A · 2 location(s) · Replimune, Inc. · NCT06887348 A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Chec
Phase 2/Phase 3 · 33 location(s) · Replimune, Inc. · NCT06581406 A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06092346

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.